Literature DB >> 21374685

Early determination of hepatitis C virus RNA may help to decide the duration of therapy for chronic hepatitis C virus genotype 2/3 infection.

Martin Lagging, Asa Alsiö, Nina Langeland, Court Pedersen, Martti Färkkilä, Mads Rauning Buhl, Kristine Mørch, Kristoffer Hellstrand, Gunnar Norkrans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21374685     DOI： 10.1002/hep.23962

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  2 in total

1.  Early quantification of HCV core antigen may help to determine the duration of therapy for chronic genotype 2 or 3 HCV infection.

Authors:  A Alsiö; A Jannesson; N Langeland; C Pedersen; M Färkkilä; M R Buhl; K Mørch; J Westin; K Hellstrand; G Norkrans; M Lagging
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-24       Impact factor: 3.267

2.  Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience.

Authors:  Jesper Waldenström; Martti Färkkilä; Karolina Rembeck; Gunnar Norkrans; Nina Langeland; Kristine Mørch; Court Pedersen; Mads Rauning Buhl; Urpo Nieminen; Hannu Nuutinen; Åsa Alsiö; Lars Holmström; Rolf Jungnelius; Katarina Lund; Anders Rubensson; Erik Torell; Johan Westin; Martin Lagging
Journal:  Scand J Gastroenterol       Date:  2015-09-29       Impact factor: 2.423
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.